DR REDDYS LABORATORIES
Back to Balance Sheet
|
DR REDDYS LABORATORIES Last 5 Year Total Debt History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Total Debt | ₹1,347 Cr | ₹3,385 Cr | ₹3,031 Cr | ₹2,210 Cr | ₹3,838 Cr |
What is the latest Total Debt ratio of DR REDDYS LABORATORIES ?
Year | Total Debt |
---|---|
Mar2023 | ₹1,347 Cr |
Mar2022 | ₹3,385 Cr |
Mar2021 | ₹3,031 Cr |
Mar2020 | ₹2,210 Cr |
Mar2019 | ₹3,838 Cr |
How is Total Debt of DR REDDYS LABORATORIES Trending?
Years | Total Debt | % Change | |
---|---|---|---|
Mar2023 | ₹1,347 Cr | -60.20 | |
Mar2022 | ₹3,385 Cr | 11.67 | |
Mar2021 | ₹3,031 Cr | 37.13 | |
Mar2020 | ₹2,210 Cr | -42.41 | |
Mar2019 | ₹3,838 Cr | - |
Compare Total Debt of peers of DR REDDYS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DR REDDYS LABORATORIES | ₹103,501.1 Cr | 5.7% | 2.7% | 29.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹360,452.0 Cr | 2.6% | -4.7% | 54.7% | Stock Analytics | |
CIPLA | ₹113,132.0 Cr | 4.4% | -4.4% | 54.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹106,191.0 Cr | 5.8% | 17.7% | 24.8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹95,954.5 Cr | 0.4% | -5.4% | 82.7% | Stock Analytics | |
MANKIND PHARMA | ₹94,779.2 Cr | -0.4% | 6% | NA | Stock Analytics |
DR REDDYS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DR REDDYS LABORATORIES | 5.7% |
2.7% |
29.3% |
SENSEX | 1% |
2.8% |
23.9% |
You may also like the below Video Courses